These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38073235)
21. H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions. van den Bent M; Saratsis AM; Geurts M; Franceschi E Neuro Oncol; 2024 May; 26(Supplement_2):S110-S124. PubMed ID: 38102230 [TBL] [Abstract][Full Text] [Related]
23. Noninvasive assessment of H3 K27M mutational status in diffuse midline gliomas by using apparent diffusion coefficient measurements. Chen H; Hu W; He H; Yang Y; Wen G; Lv X Eur J Radiol; 2019 May; 114():152-159. PubMed ID: 31005167 [TBL] [Abstract][Full Text] [Related]
24. Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort. Odia Y; Hall MD; Cloughesy TF; Wen PY; Arrillaga-Romany I; Daghistani D; Mehta MP; Tarapore RS; Ramage SC; Allen JE Neuro Oncol; 2024 May; 26(Supplement_2):S165-S172. PubMed ID: 38386699 [TBL] [Abstract][Full Text] [Related]
25. Diffuse midline glioma with H3 K27M mutation of the spinal cord: A series of 33 cases. Yao J; Wang L; Ge H; Yin H; Piao Y Neuropathology; 2021 Jun; 41(3):183-190. PubMed ID: 33599007 [TBL] [Abstract][Full Text] [Related]
26. Deep Learning for Noninvasive Assessment of H3 K27M Mutation Status in Diffuse Midline Gliomas Using MR Imaging. Li J; Zhang P; Qu L; Sun T; Duan Y; Wu M; Weng J; Li Z; Gong X; Liu X; Wang Y; Jia W; Su X; Yue Q; Li J; Zhang Z; Barkhof F; Huang RY; Chang K; Sair H; Ye C; Zhang L; Zhuo Z; Liu Y J Magn Reson Imaging; 2023 Sep; 58(3):850-861. PubMed ID: 36692205 [TBL] [Abstract][Full Text] [Related]
27. Magnetic Resonance Imaging Characteristics of Molecular Subgroups in Pediatric H3 K27M Mutant Diffuse Midline Glioma. Hohm A; Karremann M; Gielen GH; Pietsch T; Warmuth-Metz M; Vandergrift LA; Bison B; Stock A; Hoffmann M; Pham M; Kramm CM; Nowak J Clin Neuroradiol; 2022 Mar; 32(1):249-258. PubMed ID: 34919158 [TBL] [Abstract][Full Text] [Related]
28. Detecting the H3F3A mutant allele found in high-grade pediatric glioma by real-time PCR. Zhang R; Han J; Daniels D; Huang H; Zhang Z J Neurooncol; 2016 Jan; 126(1):27-36. PubMed ID: 26376656 [TBL] [Abstract][Full Text] [Related]
29. Diffuse midline gliomas with histone H3-K27M mutation: A rare case with PNET-like appearance and neuropil-like islands. Gao Y; Feng YY; Yu JH; Li QC; Qiu XS; Wang EH Neuropathology; 2018 Apr; 38(2):165-170. PubMed ID: 28880421 [TBL] [Abstract][Full Text] [Related]
31. Molecular and clinical characterization of H3 K27M-mutant "non-midline" glioblastoma: A case report and literature review. Onishi S; Ohba S; Kuraoka K; Kurashige T; Sugiyama K; Yamasaki F Neurocirugia (Astur : Engl Ed); 2022; 33(6):356-360. PubMed ID: 36333093 [TBL] [Abstract][Full Text] [Related]
32. A rare case of adult diffuse midline glioma with H3 K27M mutant in the prepontine cistern. Chen X; Zhong L; Lin J; Yu J J Int Med Res; 2021 Jan; 49(1):300060520981266. PubMed ID: 33435779 [TBL] [Abstract][Full Text] [Related]
33. High frequency of H3 K27M mutations in adult midline gliomas. Ebrahimi A; Skardelly M; Schuhmann MU; Ebinger M; Reuss D; Neumann M; Tabatabai G; Kohlhof-Meinecke P; Schittenhelm J J Cancer Res Clin Oncol; 2019 Apr; 145(4):839-850. PubMed ID: 30610375 [TBL] [Abstract][Full Text] [Related]
34. ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma. Arrillaga-Romany I; Gardner SL; Odia Y; Aguilera D; Allen JE; Batchelor T; Butowski N; Chen C; Cloughesy T; Cluster A; de Groot J; Dixit KS; Graber JJ; Haggiagi AM; Harrison RA; Kheradpour A; Kilburn LB; Kurz SC; Lu G; MacDonald TJ; Mehta M; Melemed AS; Nghiemphu PL; Ramage SC; Shonka N; Sumrall A; Tarapore RS; Taylor L; Umemura Y; Wen PY J Clin Oncol; 2024 May; 42(13):1542-1552. PubMed ID: 38335473 [TBL] [Abstract][Full Text] [Related]
35. Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes. Huang T; Garcia R; Qi J; Lulla R; Horbinski C; Behdad A; Wadhwani N; Shilatifard A; James C; Saratsis AM Oncotarget; 2018 Dec; 9(98):37112-37124. PubMed ID: 30647848 [TBL] [Abstract][Full Text] [Related]
36. Diffuse Midline Gliomas With Histone H3 K27M Mutation in Adults and Children: A Retrospective Series of 164 Cases. Zheng L; Gong J; Yu T; Zou Y; Zhang M; Nie L; Chen X; Yue Q; Liu Y; Mao Q; Zhou Q; Chen N Am J Surg Pathol; 2022 Jun; 46(6):863-871. PubMed ID: 35416795 [TBL] [Abstract][Full Text] [Related]
38. Identification of genes functionally involved in the detrimental effects of mutant histone H3.3-K27M in Drosophila melanogaster. Berlandi J; Chaouch A; De Jay N; Tegeder I; Thiel K; Shirinian M; Kleinman CL; Jeibmann A; Lasko P; Jabado N; Hasselblatt M Neuro Oncol; 2019 May; 21(5):628-639. PubMed ID: 30715493 [TBL] [Abstract][Full Text] [Related]
39. Impact of H3.3 K27M Mutation on Prognosis and Survival of Grade IV Spinal Cord Glioma on the Basis of New 2016 World Health Organization Classification of the Central Nervous System. Yi S; Choi S; Shin DA; Kim DS; Choi J; Ha Y; Kim KN; Suh CO; Chang JH; Kim SH; Yoon DH Neurosurgery; 2019 May; 84(5):1072-1081. PubMed ID: 29718432 [TBL] [Abstract][Full Text] [Related]
40. Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations. Solomon DA; Wood MD; Tihan T; Bollen AW; Gupta N; Phillips JJ; Perry A Brain Pathol; 2016 Sep; 26(5):569-80. PubMed ID: 26517431 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]